NewsBenzingaSunshine Biopharma introduce compresse generiche di Ondansetron da 4 mg e 8 mg sul mercato canadese Sunshine Biopharma introduce compresse generiche di Ondansetron da 4 mg e 8 mg sul mercato canadese Benzinga 2026.09.24 13:02 (GMT+0) Open on Benzinga Other news Sell Eagle Point Credit Now – Match The Loss With Portfolio Gains To Lower Income Taxes 3 Bear Put Spread Trade Ideas For This Monday What to Expect From Coherent's Next Quarterly Earnings Report Netflix Stock Might be a Sleeper Hit 'Europe’s Top Carriers Explore Satellite Group to Fend Off SpaceX' - Bloomberg HC Wainwright & Co. Reiterates Buy on Zentalis Pharmaceuticals, Maintains $10 Price Target
